InvestSMART

Microba Life Sciences Limited (ASX: MAP) - Announcements

Current share price for MAP : $0.053 0.004 (7.02%)+

ASX company news and announcements for Microba Life Sciences Limited (MAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Microba Life Sciences Limited (MAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Microba Life Sciences Limited (MAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Microba Life Sciences Limited (MAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$38 Letter to Shareholders, Notice of AGM & Proxy Form 28 Oct 2024 3:48PM $0.165 $0.053 fallen by 67.88%
$38 Details of Q1 FY25 Quarterly Report, Appendix 4C & Webinar 23 Oct 2024 9:24AM $0.165 $0.053 fallen by 67.88%
$38 Strategic transfer of Microba Research Services Unit to CMC 10 Oct 2024 9:10AM $0.175 $0.053 fallen by 69.71%
$38 Date of AGM and Closing Date for Director Nominations 2 Oct 2024 9:13AM $0.180 $0.053 fallen by 70.56%
$38 Microba Presents at ASX Small & Mid Cap Conference 25 Sep 2024 9:08AM $0.173 $0.053 fallen by 69.28%
$38 Change of Joint Company Secretary Role 2 Sep 2024 1:20PM $0.185 $0.053 fallen by 71.35%
$38 2024 Annual Report & Appendix 4E 29 Aug 2024 9:10AM $0.185 $0.053 fallen by 71.35%
$38 2024 Appendix 4G 29 Aug 2024 9:08AM $0.185 $0.053 fallen by 71.35%
$38 2024 Corporate Governance Statement 29 Aug 2024 9:08AM $0.185 $0.053 fallen by 71.35%
$38 Q4 FY24 Quarterly Investor Presentation & Webinar 25 Jul 2024 9:11AM $0.180 $0.053 fallen by 70.56%
$38 Q4 FY24 Quarterly Activities Report & Appendix 4C 25 Jul 2024 9:04AM $0.180 $0.053 fallen by 70.56%
$38 Details of Q4 FY24 Quarterly Report, Appendix 4C & Webinar 23 Jul 2024 9:03AM $0.170 $0.053 fallen by 68.82%
$38 Microba Diagnostics Business Update to Bioshares Summit 12 Jul 2024 9:18AM $0.168 $0.053 fallen by 68.36%
$38 Notification of cessation of securities - MAP 10 Jul 2024 5:33PM $0.185 $0.053 fallen by 71.35%
$38 Completion of Autoimmune Program with Ginkgo Bioworks 28 Jun 2024 9:02AM $0.165 $0.053 fallen by 67.88%
$38 Release of Securities from Voluntary Escrow 25 Jun 2024 5:25PM $0.165 $0.053 fallen by 67.88%
$38 Notification of cessation of securities - MAP 3 Jun 2024 9:01AM $0.200 $0.053 fallen by 73.50%
$38 Q3 FY24 Quarterly Investor Presentation 23 Apr 2024 9:08AM $0.170 $0.053 fallen by 68.82%
$38 Q3 FY24 Quarterly Activities Report & Appendix 4C 23 Apr 2024 9:04AM $0.170 $0.053 fallen by 68.82%
$38 Details of Q3 FY24 Quarterly Report, Appendix 4C & Webinar 18 Apr 2024 9:29AM $0.170 $0.053 fallen by 68.82%
$38 Microba Launches Investor Hub for Investor Engagement 16 Apr 2024 9:08AM $0.170 $0.053 fallen by 68.82%
$38 Microba receives $6.08 million R&D Tax Incentive Refund 10 Apr 2024 11:14AM $0.190 $0.053 fallen by 72.11%
$38 Notification of cessation of securities - MAP 10 Apr 2024 10:59AM $0.200 $0.053 fallen by 73.50%
$38 Ceasing to be a substantial holder 5 Apr 2024 9:04AM $0.200 $0.053 fallen by 73.50%
$38 Application for quotation of securities - MAP 5 Apr 2024 9:00AM $0.200 $0.053 fallen by 73.50%

126 - 150 of 693 results

Page 6 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.